Pediatric hyperlipidemia
- PMID: 38599724
- PMCID: PMC11019319
- DOI: 10.1016/j.ihj.2023.11.269
Pediatric hyperlipidemia
Abstract
The leading cause of mortality worldwide is atherosclerotic cardiovascular disease. Atherosclerotic plaques are well known to originate early in the childhood. Identifying hyperlipidemia in early childhood creates an opportunity to prevent major cardiovascular events in adults. Children with identified risk factors are at an increased risk of developing cardiovascular incidents in later life. This article emphasizes the diagnosis and management of pediatric hyperlipidemia with reference to the recent guidelines. In terms of etiology pediatric hyperlipidemia are divided into primary and secondary causes. The mainstay of management includes high-risk target screening, early risk factor identification and lifestyle modifications in vulnerable population. Drug therapy is recommended in primary hyperlipidemia and in children with no response to lifestyle changes.
Keywords: Cardiovascular diseases; Dyslipidemia; Hyperlipidemia; Pediatric; Pharmacotherapy.
Copyright © 2023 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Writing Group Members. Thom T., Haase N., Rosamond W., et al. Heart disease and stroke statistics—2006 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2006;113(6):e85–e151. - PubMed
-
- Kavey R.E., Daniels S.R., Lauer R.M., et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. Circulation. 2003;107(11):1562–1566. - PubMed
-
- McGill H.C., Jr., McMahan C.A., Zieske A.W., et al. Effects of nonlipid risk factors on atherosclerosis in youth with a favorable lipoprotein profile. Circulation. 2001;103(11):1546–1550. - PubMed
-
- National Heart Lung and Blood Institute . US Department of Health and Human Services, National Institutes of Health. National Institutes of Health; Bethesda, MD: 2012. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents.
-
- Wilson D.P., McNeal C., Blackett P. Pediatric dyslipidemia: recommendations for clinical management. South Med J. 2015;108(1):7–14. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
